Attached files
| file | filename |
|---|---|
| EX-4.7 - EX-4.7 - Timber Pharmaceuticals, Inc. | a2229972zex-4_7.htm |
| EX-4.6 - EX-4.6 - Timber Pharmaceuticals, Inc. | a2229972zex-4_6.htm |
| EX-4.5 - EX-4.5 - Timber Pharmaceuticals, Inc. | a2229972zex-4_5.htm |
| S-1 - S-1 - Timber Pharmaceuticals, Inc. | a2229972zs-1.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of our report (which contains an explanatory paragraph relating to the Company's ability to continue as a going concern as described in Note 2 to the consolidated financial statements) dated May 2, 2016, relating to the consolidated financial statements of BioPharmX Corporation, which appears in the Annual Report on Form 10-K of BioPharmX Corporation for the year ended January 31, 2016. We also consent to the reference of our firm under the heading "Experts" in such Registration Statement.
/s/
Burr Pilger Mayer, Inc.
San Jose, California
October 13, 2016
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM